Related Experiment Videos
Management of 'pan-negative' melanoma: current and emerging strategies
Douglas B Johnson1,1, Chengwei Peng2,2, Igor Puzanov1,1
1Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, 2220 Pierce Avenue, 777 Preston Research Building, Nashville, TN 37232, USA.
Melanoma Management
|September 8, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Tumor NLRP3 Amplification Promotes Immunotherapy Resistance by Inhibiting STAT1 Signaling and MHC Class I Expression.
The Journal of clinical investigation·2026
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.
Journal for immunotherapy of cancer·2026
An Indolent Enteropathy Accelerated by Combination Immune Checkpoint Inhibitor Therapy.
ACG case reports journal·2026
Bridging gaps throughout a patient's journey with melanoma: a systematic review.
Melanoma management·2025
Receptor Co‑targeting Strategies for Personalized Ovarian Cancer Therapy.
International journal of nanomedicine·2026
A germline KDM3C polymorphism impairs DNA repair and sensitizes to chemoradiotherapy.
medRxiv : the preprint server for health sciences·2026
Protective Effect of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) on Liver Function: Results From MELD Analysis in Surgical Revascularization-A Preliminary Study.
Medical science monitor : international medical journal of experimental and clinical research·2026